本页面由Tiger Trade Technology Pte. Ltd.提供服务

伊诺维奥制药

1.12
-0.0300-2.61%
成交量:112.83万
成交额:130.10万
市值:1.15亿
市盈率:-1.08
高:1.18
开:1.16
低:1.12
收:1.15
52周最高:2.72
52周最低:0.5632
股本:1.03亿
流通股本:9,578.70万
量比:1.01
换手率:1.18%
股息:- -
股息率:- -
每股收益(TTM):-1.0338
每股收益(LYR):-1.8117
净资产收益率:-409.87%
总资产收益率:-84.23%
市净率:26.39
市盈率(LYR):-0.62

数据加载中...

2026/10/06

重要事件披露

Form 8-K - Current report
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/31

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/31

重要事件披露

Form 8-K - Current report
2026/07/30

重要事件披露

Form 8-K - Current report
2026/05/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/06

重要事件披露

Form 8-K - Current report
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/13

重要事件披露

Form 8-K - Current report
2026/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]